In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy [5]

British Journal of Haematology

Volumn 132, Issue 5, 2006, Pages 656-658

  Prentice, A G ^a   Glasmacher, A ^b   Djulbegovic, B ^c  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BONN   (Germany)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Fluconazole; Haematological malignancy; Itraconazole; Systemic fungal infection

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; VINCA ALKALOID; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ASPERGILLOSIS; ASPERGILLUS; BONE MARROW TRANSPLANTATION; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDIASIS; CLINICAL TRIAL; DATA ANALYSIS; DRUG EFFICACY; DRUG SAFETY; HEMATOLOGIC MALIGNANCY; HUMAN; INFECTION PREVENTION; INFECTION RISK; LETTER; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW; SYSTEMIC MYCOSIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANTIFUNGAL AGENTS; FLUCONAZOLE; HEMATOLOGIC NEOPLASMS; HUMANS; ITRACONAZOLE; MYCOSES; OPPORTUNISTIC INFECTIONS;

EID: 33644916399     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.05967.x     Document Type: Letter

References (12)

1. Andes D. 2004 Clinical utility of antifungal pharmacokinetics and pharmacodynamics Current Opinion in Infectious Disease 24 533 540
2. Chen C.S. Boeckh M. Seidel K. Clark J.G. Kansu E. Madtes D.K. Wagner J.L. Witherspoon R.P. Anasetti C. Appelbaum F.R. Bensinger W.I. Deeg H.J. Martin P.J. Sanders J.E. Storb R. Storek J. Wade J. Siadak M. Flowers M.E. Sullivan K.M. 2003 Incidence, risk factors, and mortality from pneumonia developing late after hemopoietic stem cell transplantation Bone Marrow Transplantation 32 515 522
3. Glasmacher A. Prentice A.G. 2005 Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies Journal of Antimicrobial Chemotherapy 56 Suppl. S1 i23 i32
4. Glasmacher A. Prentice A.G. Gorscluter M. Engelhart S. Han C. Djulbegovic B. Scmidt-Wolf I.G.H. 2003 Itraconazole prevents invasive fungal infections in neutropenic patients treated for haematological malignancies: Evidence from a meta-analysis of 3,597 patients Journal of Clinical Oncology 21 4616 4626
5. Jantunen E. Ruutu P. Niskanen L. Parkkali T. Koukila-Kahkola P. Ruutu T. 1997 Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients Bone Marrow Transplanation 19 801 808
6. Marr K.A. Seidel K. Slavin M.A. Bowden R.A. Schoch H.G. Flowers M.E. Corey L. Boeckh M. 2000 prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomised, placebo-controlled trial Blood 96 2055 2061
7. Marr K. Carter R.A. Boeckh M. Martin P. Corey L. 2002 Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors Blood 100 4358 4366
8. Martino R. Subira M. Rovira M. Solano C. Vazquez L. Sanz G.F. Urbano-Ispizua A. Brunet S. De la Camara R. 2002 Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients British Journal of Haematology 116 475 482
9. Perfect J.R. Klotman M.E. Gilbert C.C. Crawford D.D. Rosner G.L. Wright K.A. Peters W.P. 1992 Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients Journal of Infectious Diseases 165 891 897
10. Riley D.K. Pavia A.T. Beatty P.G Petersen F.B. Spruance J.L. Stokes R. Evans T.G. 1994 The prophylactic use of low-dose amphotericin B in bone marrow transplant patients American Journal of Medicine 97 509 514
11. Vardakas K.Z. Michalopoulos A. Falagas M.E. 2005 Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials British Journal of Haematology 131 22 28
12. Wald A. Leisenring W. van Burik J-A. Bowden R.A. 1997 Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation Journal of Infectious Diseases 175 1459 1466